(2004). AK: TGF-beta1, FGF2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures. Plast Reconstr Surg
(2006). BMP and BMP inhibitors in bone.
(2003). De Schepper AM: Pictorial essay. Myositis ossificans circumscripta. JBR-BTR
(2004). Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum
(2003). DM: Multiple joint and skeletal patterning defects caused by single and double mutations
(2003). EM: Bone morphogenetic protein4 regulation in fibrodysplasia ossificans progressiva. Clin Orthop Relat Res
(2004). EM: Heterotopic ossification.
(2003). EM: In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am
(1998). Fibrodysplasia (myositis) ossificans progressiva. Clinical lessons from a rare disease. Clin Orthop Relat Res
(2000). Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. Am J Hum Genet
(1996). FS: Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.
(2003). FS: Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.
(1996). FS: Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
(2001). HF: Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification. Biochem Biophys Res Commun